Su D.-H.Lai M.-Y.HUEY-PEIR WU2021-08-232021-08-2320060742-3071https://www.scopus.com/inward/record.uri?eid=2-s2.0-33645064541&doi=10.1111%2fj.1464-5491.2006.01791.x&partnerID=40&md5=843ee55408cb32f1bf79efde798afe01https://scholars.lib.ntu.edu.tw/handle/123456789/579125[SDGs]SDG3glibenclamide; metformin; rosiglitazone; troglitazone; abnormally high substrate concentration in blood; add on therapy; adult; anamnesis; anorexia; blood clotting test; case report; clinical examination; clinical feature; diabetes mellitus; disease exacerbation; epigastric pain; female; hepatitis B; human; hyperbilirubinemia; jaundice; laboratory test; letter; liver failure; liver function test; liver toxicity; male; nausea; partial thromboplastin time; physical examination; thrombocytopenia; treatment withdrawal; Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; Liver Failure; Liver Function Tests; Middle Aged; Thiazolidinedionesletter10.1111/j.1464-5491.2006.01791.x164095772-s2.0-33645064541